- Home
- / ARIAD Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
ARIAD Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$118.8 M
FY, 2015
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 |
|---|---|---|---|---|---|
| Revenue | 25.3M | 558.0K | 45.6M | 105.4M | 118.8M |
| Revenue growth, % | 131.4% | 12.7% | |||
| Cost of goods sold | 9.6M | 5.2M | 2.1M | ||
| Gross profit | 35.9M | 100.2M | 116.7M | ||
| Gross profit margin, % | 78.9% | 95.0% | 98.2% | ||
| General and administrative expense | 24.4M | 60.9M | 146.6M | 139.8M | 162.8M |
| Operating expense total | 102.1M | 205.6M | 309.5M | 260.4M | 334.0M |
| EBIT | (76.8M) | (205.1M) | (273.6M) | (160.2M) | (217.3M) |
| EBIT margin, % | -303.6% | -36749.1% | -600.4% | -152.0% | -182.9% |
| Interest income | 167.0K | 240.0K | 130.0K | 85.0K | 82.0K |
| Interest expense | 232.0K | 199.0K | 153.0K | 1.8M | 17.3M |
| Pre tax profit | (273.7M) | (162.0M) | (234.5M) | ||
| Income tax expense | 439.0K | 630.0K | (3.4M) | ||
| Net Income | (123.6M) | (220.9M) | (274.2M) | (162.6M) | (231.2M) |